Depression. Major depressive disorder, single episode, mild
Conditions
Interventions
Intervention 1: Intervention group: The intervention group (33 people) will receive niacin (Abidi Pharmaceuticals co.) supplement in addition to EScitalopram (Abidi Pharmaceuticals co.) as an anti-dep
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Score 11 to 18 in Hamilton depression test Diagnosis of mild and moderate depression based on structured interview based on DSM-5 and Hamilton index Age 18 to 60 years
Exclusion criteria
Exclusion criteria: Received electric shock in the last two months Thyroid diseases Psychotic disorder pregnant women severe depression Allergy to niacin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score. Timepoint: Before the intervention, 2, 4, and 8 weeks after the intervention. Method of measurement: Clinical examination with Hamilton's index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of niacin. Timepoint: Before the intervention, 2, 4, and 8 weeks after the intervention. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholamhasan Esfahani
Ahvaz University of Medical Sciences
Outcome results
None listed